Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

Clinical trial NCT07630454 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07630454
Sponsor: Yunlong Wang
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Heart Failure With Preserved Ejection Fraction (HFpEF)Tirzepatide

Start date: 2026-08-01
Primary completion: 2029-08-01
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.